Longeveron (LGVN) Return on Equity (2022 - 2026)
Longeveron (LGVN) recorded quarterly Return on Equity of 0.02% in Q1 2026, up 29.18% quarter-over-quarter from 0.03% in Q4 2025, and down 1.0% on a YoY basis from 0.02% in Q1 2025.
Longeveron (LGVN) Return on Equity (2022 - 2026) Analysis & Trends
Longeveron's Return on Equity history runs 5 years deep, the most recent figure standing at 0.02% for Q1 2026.
- In Q1 2026, Return on Equity fell 1.0% year-over-year to 0.02%; the TTM figure through Mar 2026 stood at 0.02% (down 1.0% YoY), while the FY2025 annual figure was 0.02%, down 1.0% from the prior year.
- Return on Equity was 0.02% for Q1 2026 at Longeveron, up from 0.03% in the prior quarter.
- In the past five years, Return on Equity ranged from a high of 0.0% in Q1 2022 to a low of 0.04% in Q1 2024.
- Historically, Return on Equity has averaged 0.02% across 5 years, with a median of 0.01% in 2025.
- The sharpest annual moves came in 2024 and 2025: Return on Equity fell 3 bps in 2024, then increased 3 bps in 2025.
- A 5-year view of Return on Equity shows it stood at 0.01% in 2022, then tumbled by 265 bps to 0.03% in 2023, then soared by 78 bps to 0.01% in 2024, then tumbled by 328 bps to 0.03% in 2025, then increased by 29 bps to 0.02% in 2026.
- The last three Return on Equity figures came in at 0.02% (Q1 2026), 0.03% (Q4 2025), and 0.02% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.81% |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -0.04% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -0.01% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.01% |
| 10 | Longeveron | 20.35 Bn | 20.33 Bn | 264,000.00 | -0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.02% |
| Dec 31, 2025 | -0.03% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.04% |
| Dec 31, 2023 | -0.03% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | 0.00% |